Here are five new biologic device launches or releases in 2018 so far:

NanoFUSE Biologics will attend the 2018 International Meeting on Advanced Spine Techniques in Los Angeles between July 11 and July 14.

Global spine service company SpineMark partnered with Regenexx Corp. to refer candidates for surgery at the company's centers for excellence.

NanoFUSE Biologics appointed Archie Yamada as vice president of product business development.

Connect Healthcare Collaboration will recommend Regenexx to its employer partners in order to offer alternatives to orthopedic surgery.

Zimmer Biomet, the former U.S. exclusive distributor for BoneSupport, cancelled a majority of its Cerament Bone Void Filler orders for a three month period starting in June.

The FDA awarded approval for a second indication of Medtronic's Kyphon HV-R Bone Cement.

Dallas-based consulting company ACAP Health partnered with interventional orthopedic physician network Regenexx to reduce orthopedic surgery costs for employers.

Kuros Biosciences will present results from clinical case studies of MagnetOs Granules at the 15th annual State of Spine Surgery Think Tank on June 21 to June 23 in Aruba.

Spine surgeon Mark McFarland, DO, performed a surgery with SpineFrontier's REmind pedicle screw system and LES P-LIFT interbody cages as well as NanoFuse Bioactive Matrix.

The FDA granted Wright Medical Group premarket approval for its Augment Injectable Bone Graft.

The University Medical Center Utrecht in the Netherlands will begin a study comparing Kuros Biosciences' MagnetOs with autologous bone in posterolateral spinal fusion.

Cerapedics earned the 2018 MedTech Breakthrough Award for Best New Surgical Technology Solution.

Tulsa, Okla.-based Edison Healthcare partnered with Regenexx to offer its employees alternatives to orthopedic surgery.

NuVasive launched the AttraX Scaffold in the U.S. for use in the posterolateral spine to promote fusion.

The global spine biologics market is expected to grow at a compound annual growth rate of 4.09 percent from 2018 to 2022, according to a 360 Market Updates report.

Lattice Biologics is a regenerative medicine company that develops biologic allograft products for bone, skin and cartilage solutions.

Here are eight Q&As on the application of biologics in orthopedics and spine.

International Stem Cell Corporation plans to launch its advanced joint supplement for the treatment of osteoarthritis-related joint pain in the third quarter of 2018.

Tracy Porter, the football legend notorious for sealing the New Orleans Saints' Super Bowl win in 2010, struggled with persistent knee pain for several seasons.